Galnt13 - polypeptide N-acetylgalactosaminyltransferase 13 Gene
Also Known as T13
Species: Rattus norvegicus
Summary
Predicted to enable polypeptide N-acetylgalactosaminyltransferase activity. Predicted to be involved in protein O-linked glycosylation via serine and protein O-linked glycosylation via threonine. Predicted to act upstream of or within protein O-linked glycosylation. Predicted to be located in Golgi membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus. Orthologous to human GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13). [provided by Alliance of Genome Resources, Apr 2022]
Galnt13 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_199106.2 | NP_954537.1 | polypeptide N-acetylgalactosaminyltransferase 13 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
polypeptide N-acetylgalactosaminyltransferase 13 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-E70294 | N-Acetylgalactosaminyltransferase 13 | / | Unkown | |
| HY-RS05251 | GALNT13 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05253 | GALNT15 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service